ID

18028

Description

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00322387

Link

https://clinicaltrials.gov/show/NCT00322387

Keywords

Versions (1)
  1. 10/15/16 10/15/16 -
Uploaded on

October 15, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lymphoma, Non-Hodgkin NCT00322387

English

Eligibility Lymphoma, Non-Hodgkin NCT00322387

1 forms  
Criteria
Description

Criteria

mm in first partial response/complete response, first relapse, or second partial/complete response
Description

Multiple Myeloma partial response First | Multiple Myeloma complete response First | Multiple Myeloma First Relapse | Multiple Myeloma partial response second | Multiple Myeloma complete response second

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C1521726
UMLS CUI [1,3]
C0205435
UMLS CUI [2,1]
C0026764
UMLS CUI [2,2]
C0677874
UMLS CUI [2,3]
C0205435
UMLS CUI [3,1]
C0026764
UMLS CUI [3,2]
C4054953
UMLS CUI [4,1]
C0026764
UMLS CUI [4,2]
C1521726
UMLS CUI [4,3]
C0205436
UMLS CUI [5,1]
C0026764
UMLS CUI [5,2]
C0677874
UMLS CUI [5,3]
C0205436
nhl in first or second partial or complete remission
Description

Non-Hodgkin Lymphoma partial response First | Non-Hodgkin Lymphoma partial response second | Non-Hodgkin Lymphoma complete remission First | Non-Hodgkin Lymphoma complete remission second

Data type

boolean

Alias
UMLS CUI [1,1]
C0024305
UMLS CUI [1,2]
C1521726
UMLS CUI [1,3]
C0205435
UMLS CUI [2,1]
C0024305
UMLS CUI [2,2]
C1521726
UMLS CUI [2,3]
C0205436
UMLS CUI [3,1]
C0024305
UMLS CUI [3,2]
C0677874
UMLS CUI [3,3]
C0205435
UMLS CUI [4,1]
C0024305
UMLS CUI [4,2]
C0677874
UMLS CUI [4,3]
C0205436
nhl patients who do not have bone marrow involvement and < 10% for follicular involvement
Description

Lymphoma, Non-Hodgkin | Bone Marrow Involvement | Involvement Follicular Percentage

Data type

boolean

Alias
UMLS CUI [1]
C0024305
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C1314939
UMLS CUI [3,1]
C1314939
UMLS CUI [3,2]
C0439682
UMLS CUI [3,3]
C0439165
mm patients who have stable disease with < 40% bone marrow involvement
Description

Multiple Myeloma Stable | Bone Marrow Percentage Involvement

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0439165
UMLS CUI [2,3]
C1314939
no more than three prior regimens of chemotherapy (thalidomide and decadron are not considered chemotherapy)
Description

Prior Chemotherapy Quantity | Thalidomide | Decadron

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0039736
UMLS CUI [3]
C0740057
eastern cooperative oncology group (ecog) performance status of 0 or 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
white blood cell count (wbc) >3.0 x 10^9/l
Description

White Blood Cell Count procedure

Data type

boolean

Alias
UMLS CUI [1]
C0023508
absolute neutrophil count >1.5 x 10^9/l
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelet count >100 x 10^9/l
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
exclusion criteria (abbreviated list):
Description

Exclusion Criteria

Data type

boolean

Alias
UMLS CUI [1]
C0680251
brain metastases or carcinomatous meningitis
Description

Metastatic malignant neoplasm to brain | Meningeal Carcinomatosis

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0220654
hypercalcaemia [>1 mg/dl above the upper limit of normal (uln)]
Description

Hypercalcemia

Data type

boolean

Alias
UMLS CUI [1]
C0020437
cardiovascular disease that includes proven or predisposition to ventricular arrhythmias
Description

Cardiovascular Diseases | Ventricular arrhythmia | Ventricular arrhythmia Predisposition

Data type

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0085612
UMLS CUI [3,1]
C0085612
UMLS CUI [3,2]
C0220898
acute infection
Description

Communicable Disease

Data type

boolean

Alias
UMLS CUI [1]
C0009450
Back to the top of the page

Similar models

Eligibility Lymphoma, Non-Hodgkin NCT00322387

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Multiple Myeloma partial response First | Multiple Myeloma complete response First | Multiple Myeloma First Relapse | Multiple Myeloma partial response second | Multiple Myeloma complete response second
Item
mm in first partial response/complete response, first relapse, or second partial/complete response
boolean
C0026764 (UMLS CUI [1,1])
C1521726 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0026764 (UMLS CUI [2,1])
C0677874 (UMLS CUI [2,2])
C0205435 (UMLS CUI [2,3])
C0026764 (UMLS CUI [3,1])
C4054953 (UMLS CUI [3,2])
C0026764 (UMLS CUI [4,1])
C1521726 (UMLS CUI [4,2])
C0205436 (UMLS CUI [4,3])
C0026764 (UMLS CUI [5,1])
C0677874 (UMLS CUI [5,2])
C0205436 (UMLS CUI [5,3])
Non-Hodgkin Lymphoma partial response First | Non-Hodgkin Lymphoma partial response second | Non-Hodgkin Lymphoma complete remission First | Non-Hodgkin Lymphoma complete remission second
Item
nhl in first or second partial or complete remission
boolean
C0024305 (UMLS CUI [1,1])
C1521726 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
C0024305 (UMLS CUI [2,1])
C1521726 (UMLS CUI [2,2])
C0205436 (UMLS CUI [2,3])
C0024305 (UMLS CUI [3,1])
C0677874 (UMLS CUI [3,2])
C0205435 (UMLS CUI [3,3])
C0024305 (UMLS CUI [4,1])
C0677874 (UMLS CUI [4,2])
C0205436 (UMLS CUI [4,3])
Lymphoma, Non-Hodgkin | Bone Marrow Involvement | Involvement Follicular Percentage
Item
nhl patients who do not have bone marrow involvement and < 10% for follicular involvement
boolean
C0024305 (UMLS CUI [1])
C0005953 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C1314939 (UMLS CUI [3,1])
C0439682 (UMLS CUI [3,2])
C0439165 (UMLS CUI [3,3])
Multiple Myeloma Stable | Bone Marrow Percentage Involvement
Item
mm patients who have stable disease with < 40% bone marrow involvement
boolean
C0026764 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C1314939 (UMLS CUI [2,3])
Prior Chemotherapy Quantity | Thalidomide | Decadron
Item
no more than three prior regimens of chemotherapy (thalidomide and decadron are not considered chemotherapy)
boolean
C1514457 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0039736 (UMLS CUI [2])
C0740057 (UMLS CUI [3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
White Blood Cell Count procedure
Item
white blood cell count (wbc) >3.0 x 10^9/l
boolean
C0023508 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count >1.5 x 10^9/l
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count >100 x 10^9/l
boolean
C0032181 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria (abbreviated list):
boolean
C0680251 (UMLS CUI [1])
Metastatic malignant neoplasm to brain | Meningeal Carcinomatosis
Item
brain metastases or carcinomatous meningitis
boolean
C0220650 (UMLS CUI [1])
C0220654 (UMLS CUI [2])
Hypercalcemia
Item
hypercalcaemia [>1 mg/dl above the upper limit of normal (uln)]
boolean
C0020437 (UMLS CUI [1])
Cardiovascular Diseases | Ventricular arrhythmia | Ventricular arrhythmia Predisposition
Item
cardiovascular disease that includes proven or predisposition to ventricular arrhythmias
boolean
C0007222 (UMLS CUI [1])
C0085612 (UMLS CUI [2])
C0085612 (UMLS CUI [3,1])
C0220898 (UMLS CUI [3,2])
Communicable Disease
Item
acute infection
boolean
C0009450 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial